The impact of the sequence of radiation and chemotherapy on local control after breast-conserving surgery

Cancer Journal from Scientific American

Volumn 2, Issue 1, 1996, Pages 39-45

  McCormick, Beryl ^a   Norton, Larry ^a   Yao, Tzy Jyun ^a   Yahalom, Joachim ^a   Petrek, Jeanne Ann ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast cancer; Chemotherapy sequencing; Local control; Radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ARTICLE; BREAST TUMOR; COMPARATIVE STUDY; DRUG THERAPY; FEMALE; HUMAN; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RETROSPECTIVE STUDY; SEGMENTAL MASTECTOMY; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DRUG THERAPY; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0003008592     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992;339:71-85.
2. Fisher B, Anderson S, Fisher ER et al. Significance of ipsilateral breast tumor recurrence after lumpectomy. Lancet 1991;338:329-331.
3. Recht A, Come SE, Gelman RS et al. Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage node-positive brast cancer: sequencing, timing, and outcome. J Clin Oncol 1991;9:1662-1667.
4. Lichter AS. Lumpectomy and radiation: improving the outcome [editorial]. J Clin Oncol 1992;3:349-351.
5. TNM Classification of Malignant Tumours. Hermanek P, Solin LH, eds. TNM Clinical Classification. New York: Springer-Verlag, 1987:95-97.
6. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Amer Stat Assoc 1958;53:457-816.
7. Cox DR. Regression models and life tables. J Roy Statis Soc 1972;34: Series B:187-220.
8. Harris JR, Connolly JL, Schnitt SJ, Cohen RB, Hellman S. Clinical-pathologic study of early breast cancer treated by primary radiation therapy. J Clin Oncol 1983;1:184-189.
9. Vicini FA, Eberlein TJ, Connolly JL et al. The optimal extent of resection of patients with stages I or II breast cancer treated with conservative surgery and radtiotherapy. Ann Surg 1991;214:200-205.
10. Recht A, Harris JR, Come SE. Sequencing of irradiation and chemotherapy for early-stage breast cancer oncology, 1994;8:19-28.
11. Boyages J, Recht A, Connolly J et al. Factors associated with local recurrence as a first site of failure following the conservative treatment of early breast cancer. Cancer Res 1989;115:93-102.
12. Fourquet A, Campana F, Zafrani B et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 1989;17:719-725.
13. Kurtz JM, Jacquemier J, Amalric R et al. Risk factors for breast cancer recurrence in premenopausal and postmenopausal patients with ductal cancer treated by conservation therapy. Cancer 1990;65:1867-1878.
14. Clarke DH, Le MG, Sarrazin D et al. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: expertise of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys 1985;11:137-145.
15. Haffty BG, Fischer D, Rose M, Beinfield M, McKhann C. Prognostic factors for local recurrence in the conservatively treated breast cancer patient: a cautious interpretation of the data. J Clin Oncol 1991;9:977-1003.
16. Bartelink H, van Tienhoven G, van Dongen JA, Fentiman IS, van der Schueren E. Locoregional recurrence after mastectomy or breast conserving therapy: analysis of clinical prognostic factors and results of salvage therapy in a randomized EORTC trial [abstract]. Int J Radiat Oncol Biol Phys 1992;24:220.
17. van Limbergen E, van den Bogaert W, van der Schueren E, Rijnders A. Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control. Radiother Oncol 1987;8:1-9.
18. Veronesi U, Salvadori B, Luini A et al. Conservative treatment of early breast cancer: long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. What's New Gen Surg 1989;211:250-259.
19. McCormick B, Begg C, Norton L, Yao T, Kinne D. Timing of radiotherapy in the treatment of early-stage breast cancer [letter]. J Clin Oncol 1993;11:191-197.
20. Buchholz TA, Thomas TW, Moe RE et al. Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys 1993;26:23-35.
21. Buzdar AU, Kau SW, Smith TL et al. Order of chemotherapy and radiation administration and its effect on local control of operable breast cancer. Cancer 1991;71:3680-3684.
22. Hartsell WF, Recine DC, Griem KL, Murthy AK. Delaying the initiation of intact breast irradiation in node-positive breat cancer increases the risk of local recurrence [abstract]. Proc Radiol Soc North Am 1992:172.
23. Antoniades J, Chen C, Gabuzda TG et al. Stage II carcinoma of the breast treated in sequence by surgery, chemotherapy and irradiation [abstract]. Proc Am Soc Clin Oncol 1993;12:83.
24. Heimann R, Powers C, Fleming G et al. Does the sequencing of radiotherapy and chemotherapy affect the outcome in early-stage breast cancer: a continuing question [abstract]. Int J Radiat Oncol Biol Phys 1994;30[Suppl 1]: 243.
25. Wood M, Leonard C, Zhen B et al. Administration of chemotherapy prior to radiation therapy may positively impact local and distant recurrence rates of breast cancer in women treated with conservative surgery [abstract]. Breast Cancer Res Treat 1994;32:46.
26. The Ludwig Breast Cancer Study Group Prolonged disease-free survival after a course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med 1989;320:491-496.
27. Lara Jimenez P, Garcia Puche J, Pedraza V. Adjuvant combined modality treatment in high risk breast cancer patients: 5th EORTC Breast Cancer Working Conference [abstract]. Oncology 1991;8:A293.
28. Bonadonna G, Valagussa P, Moliterni A, Zambetti M, Brambilla C. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer. New Engl J Med 1995;332:901-906.